Stocks and Investing Stocks and Investing
Thu, September 30, 2021
Wed, September 29, 2021

Matthew Biegler Initiated (ZNTL) at Buy and Held Target at $90 on, Sep 29th, 2021


Published on 2024-10-27 18:01:28 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $90 on, Sep 29th, 2021.

Matthew, nor any peers, have made any analyst calls on ZNTL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources